Ziad Boujaoude1, Nagendra Madisi1, Bhavi Patel1, Jean-Sebastien Rachoin2, R Phillip Dellinger2, Wissam Abouzgheib1. 1. Division of Pulmonary and Interventional Pulmonary Medicine, Department of Medicine, Cooper University Health Care, Cooper Medical School of Rowan University, Camden, NJ, USA. 2. Division of Critical Care Medicine, Department of Medicine, Cooper University Health Care, Cooper Medical School of Rowan University, Camden, NJ, USA.
Abstract
INTRODUCTION: The rapidly spreading Novel Coronavirus 2019 (COVID-19) appeared to be a highly transmissible pathogen in healthcare environments and had resulted in a significant number of patients with respiratory failure requiring tracheostomy, an aerosol-generating procedure that places healthcare workers at high risk of contracting the infection. Instead of deferring or delaying the procedure, we developed and implemented a novel percutaneous dilatational tracheostomy (PDT) protocol aimed at minimizing the risk of transmission while maintaining favorable procedural outcome. Patients and Methods. All patients who underwent PDT per novel protocol were included in the study. The key element of the protocol was the use of apnea during the critical part of the insertion and upon any opening of the ventilator circuit. This was coupled with the use of enhanced personnel protection equipment (PPE) with a powered air-purifying respirator (PAPR). The operators underwent antibody serology testing and were evaluated for COVID-19 symptoms two weeks from the last procedure included in the study. RESULTS: Between March 12th and June 30th, 2020, a total of 32 patients underwent PDT per novel protocol. The majority (80%) were positive for COVID-19 at the time of the procedure. The success rate was 94%. Only one patient developed minor self-limited bleeding. None of the proceduralists developed positive serology or any symptoms compatible with COVID-19 infection. CONCLUSION: A novel protocol that uses periods of apnea during opening of the ventilator circuit along with PAPR-enhanced PPE for PDT on COVID-19 patients appears to be effective and safe for patients and healthcare providers.
INTRODUCTION: The rapidly spreading Novel Coronavirus 2019 (COVID-19) appeared to be a highly transmissible pathogen in healthcare environments and had resulted in a significant number of patients with respiratory failure requiring tracheostomy, an aerosol-generating procedure that places healthcare workers at high risk of contracting the infection. Instead of deferring or delaying the procedure, we developed and implemented a novel percutaneous dilatational tracheostomy (PDT) protocol aimed at minimizing the risk of transmission while maintaining favorable procedural outcome. Patients and Methods. All patients who underwent PDT per novel protocol were included in the study. The key element of the protocol was the use of apnea during the critical part of the insertion and upon any opening of the ventilator circuit. This was coupled with the use of enhanced personnel protection equipment (PPE) with a powered air-purifying respirator (PAPR). The operators underwent antibody serology testing and were evaluated for COVID-19 symptoms two weeks from the last procedure included in the study. RESULTS: Between March 12th and June 30th, 2020, a total of 32 patients underwent PDT per novel protocol. The majority (80%) were positive for COVID-19 at the time of the procedure. The success rate was 94%. Only one patient developed minor self-limited bleeding. None of the proceduralists developed positive serology or any symptoms compatible with COVID-19 infection. CONCLUSION: A novel protocol that uses periods of apnea during opening of the ventilator circuit along with PAPR-enhanced PPE for PDT on COVID-19 patients appears to be effective and safe for patients and healthcare providers.
Authors: Abesh Niroula; Keriann M Van Nostrand; Onkar V Khullar; Seth Force; Wissam S Jaber; Alejandro H Sardi; David M Berkowitz Journal: Crit Care Explor Date: 2020-05-22
Authors: Babak Givi; Bradley A Schiff; Steven B Chinn; Daniel Clayburgh; N Gopalakrishna Iyer; Scharukh Jalisi; Michael G Moore; Cherie-Ann Nathan; Lisa A Orloff; James P O'Neill; Noah Parker; Chad Zender; Luc G T Morris; Louise Davies Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-06-01 Impact factor: 6.223
Authors: Christopher M Petrilli; Simon A Jones; Jie Yang; Harish Rajagopalan; Luke O'Donnell; Yelena Chernyak; Katie A Tobin; Robert J Cerfolio; Fritz Francois; Leora I Horwitz Journal: BMJ Date: 2020-05-22
Authors: Alfons Torrego; Virginia Pajares; Carmen Fernández-Arias; Paula Vera; Jordi Mancebo Journal: Am J Respir Crit Care Med Date: 2020-07-15 Impact factor: 21.405
Authors: Phillip Staibano; Marc Levin; Tobial McHugh; Michael Gupta; Doron D Sommer Journal: JAMA Otolaryngol Head Neck Surg Date: 2021-07-01 Impact factor: 8.961